Contemporary Mortality Differences Between Primary Percutaneous Coronary Intervention and Thrombolysis in ST-Segment Elevation Myocardial Infarction

被引:0
|
作者
Claeys, Marc J. [1 ]
de Meester, Antoine [2 ]
Convens, Carl [3 ]
Dubois, Philippe [4 ]
Boland, Jean [5 ]
De Raedt, Herbert [6 ]
Vranckx, Pascal [7 ]
Coussement, Patrick [8 ]
Gevaert, Sofie [9 ]
Sinnaeve, Peter [10 ]
Evrard, Patrick [11 ]
Beauloye, Christophe [12 ]
Renard, Marc [13 ]
Vrints, Christiaan [1 ]
机构
[1] Univ Antwerp Hosp, Dept Cardiol, B-2650 Edegem, Belgium
[2] Hop Jolimont, Dept Cardiol, Haine St Paul, Belgium
[3] Ziekenhuis Netwerk Antwerpen, Dept Cardiol, Antwerp, Belgium
[4] Ctr Hosp Univ Charleroi, Dept Cardiol, Charleroi, Belgium
[5] Ctr Hosp Reg Citadelle Liege, Dept Cardiol, Liege, Belgium
[6] Onze Lieve Vrouwziekenhuis Ziekenhuis Aalst, Dept Cardiol, Aalst, Belgium
[7] Virga Jesse Ziekenhuis, Dept Cardiol, Hasselt, Belgium
[8] AZ Sint Jan Brugge, Dept Cardiol, Brugge, Belgium
[9] Univ Ziekenhuis Gent, Dept Cardiol, Ghent, Belgium
[10] Univ Ziekenhuis Leuven, Dept Cardiol, Leuven, Belgium
[11] UCL Mt Godinne, Dept Cardiol, Yvoir, Belgium
[12] UCL Louvain, Dept Cardiol, Louvain, Belgium
[13] Univ Libre Bruxelles, Brussels, Belgium
关键词
TIMI RISK SCORE; PRIMARY ANGIOPLASTY; IMMEDIATE ANGIOPLASTY; REPERFUSION THERAPY; HOSPITAL MORTALITY; NATIONAL REGISTRY; LONG; MANAGEMENT; TRIAL; FIBRINOLYSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Current ST-segment elevation myocardial infarction guidelines regarding reperfusion strategy are based on trials conducted before the application of routine invasive evaluation after thrombolysis. Modern thrombolysis may affect the previously observed mortality difference between primary percutaneous coronary intervention (PPCI) and thrombolysis. Methods: In-hospital mortality was prospectively assessed in 5295 patients with ST-segment elevation myocardial infarction admitted to 73 Belgian hospitals from July 1, 2007, through December 31, 2009. A total of 4574 patients (86.4%) were treated with PPCI and 721 (13.6%) received thrombolysis; of these thrombolysis patients, 603 (83.6%) underwent subsequent invasive evaluation. The Thrombolysis in Myocardial Infarction risk score was used to stratify the study population by low (n = 1934), intermediate (n = 2382), and high (n = 979) risk. Results: In-hospital mortality in the PPCI patients was 5.9% vs 6.6% in the thrombolysis patients. After adjustment for differences in baseline risk profile, a significant mortality benefit was only present in the high-risk groups: 23.7% in the PPCI patients vs 30.6% in the thrombolysis patients. For patients not at high risk, the mortality difference was marginal. For low-risk patients, mortality was 0.3% in the PPCI patients vs 0.4% in the thrombolysis patients. For intermediate-risk patients, mortality was 2.9% in the PPCI patients vs 3.1% in the thrombolysis patients. Subgroup analysis revealed that the mortality benefit of PPCI compared with early thrombolysis (door-to-needle time <30 minutes) was offset if the door-to-balloon time exceeded 60 minutes. Conclusions: Modern thrombolytic strategies have substantially attenuated the absolute mortality benefit of PPCI over thrombolysis, particularly in patients not at high risk. Our study findings suggest that target door-to-balloon time should be less than 60 minutes to maintain the lowest mortality rates.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 50 条
  • [31] Impact of smoking on outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Bujak, Marta
    Desperak, Aneta
    Gierlotka, Marek
    Milewski, Krzysztof
    Wita, Krystian
    Kalarus, Zbigniew
    Fluder-Wlodarczyk, Joanna
    Pawlus, Pawel
    Buszman, Pawel E.
    Piegza, Jacek
    Wojakowski, Wojciech
    Gasior, Pawel
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023,
  • [32] Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction
    Kang, Won Yu
    Jeong, Myung Ho
    Ahn, Young Keun
    Kim, Jong Hyun
    Chae, Shung Chull
    Kim, Young Jo
    Hur, Seung Ho
    Seong, In Whan
    Hong, Taek Jong
    Choi, Dong Hoon
    Cho, Myeong Chan
    Kim, Chong Jin
    Seung, Ki Bae
    Chung, Wook Sung
    Jang, Yang Soo
    Rha, Seung Woon
    Bae, Jang Ho
    Cho, Jeong Gwan
    Park, Seung Jung
    JOURNAL OF CARDIOLOGY, 2010, 55 (01) : 84 - 91
  • [33] Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Piccolo, Raffaele
    Eitel, Ingo
    Galasso, Gennaro
    Iversen, Allan Zeeberg
    Gu, Youlan L.
    Dominguez-Rodriguez, Alberto
    de Smet, Bart J. G. L.
    Mahmoud, Karim D.
    Abreu-Gonzalez, Pedro
    Thiele, Holger
    Piscione, Federico
    VASCULAR PHARMACOLOGY, 2015, 73 : 32 - 37
  • [34] Outcomes of Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients With Previous Coronary Bypass Surgery
    Kohl, Louis P.
    Garberich, Ross F.
    Yang, Hannah
    Sharkey, Scott W.
    Burke, M. Nicholas
    Lips, Daniel L.
    Hildebrandt, David A.
    Larson, David M.
    Henry, Timothy D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (09) : 981 - 987
  • [35] Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction A Contemporary Review and Argument for Percutaneous Coronary Intervention
    Lee, Michael S.
    Bokhoor, Pooya
    Park, Seung-Jung
    Kim, Young-Hak
    Stone, Gregg W.
    Sheiban, Imad
    Biondi-Zoccai, Giuseppe
    Sillano, Dario
    Tobis, Jonathan
    Kandzari, David E.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (08) : 791 - 795
  • [36] Role of ST-Segment Resolution Alone and in Combination With TIMI Flow After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction
    Wu, Chao
    Gao, Xiaojin
    Li, Ling
    Jing, Quanmin
    Li, Weimin
    Xu, Haiyan
    Zhang, Wenbo
    Li, Sidong
    Zhao, Yanyan
    Wang, Yang
    Li, Wei
    Wu, Yongjian
    Hu, Fenghuan
    Jin, Chen
    Qiao, Shubin
    Yang, Jingang
    Yang, Yuejin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
  • [37] Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock
    Kochar, Ajar
    Al-Khalidi, Hussein R.
    Hansen, Steen M.
    Shavadia, Jay S.
    Roettig, Mayme L.
    Fordyce, Christopher B.
    Doerfler, Shannon
    Gersh, Bernard J.
    Henry, Timothy D.
    Berger, Peter B.
    Jollis, James G.
    Granger, Christopher B.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (18) : 1824 - 1833
  • [38] The Usefulness of Myeloperoxidase in Prediction of In-Hospital Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
    Stankovic, Sanja
    Asanin, Milika
    Majkic-Singh, Nada
    Ignjatovic, Svetlana
    Mihailovic, Mirjana
    Nikolajevic, Ivica
    Mrdovic, Igor
    Matic, Dragan
    Savic, Lidija
    Marinkovic, Jelena
    Ostojic, Miodrag
    Vasiljevic, Zorana
    CLINICAL LABORATORY, 2012, 58 (1-2) : 125 - 131
  • [39] Bedside prediction of 9-year mortality after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Polanska-Skrzypczyk, Magdalena
    Karcz, Maciej
    Ruzyllo, Witold
    Witkowski, Adam
    KARDIOLOGIA POLSKA, 2019, 77 (7-8) : 703 - 709
  • [40] Relation of Pain-to-Balloon Time and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Zahler, David
    Rozenfeld, Keren-Lee
    Pasternak, Yotam
    Itach, Tamar
    Lupu, Lior
    Banai, Shmuel
    Shacham, Yacov
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 163 : 38 - 42